person · Reporting owner

Maldonado John L.

Disclosed activity across 3 companies

Tapewire entity: 137872
SEC CIK: 0001544918

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
ATI Physical Therapy, Inc.ATIP · Entity 79823	Director	June 16, 2021	June 28, 2021
Syneos Health, Inc.SYNH · Entity 109360	Director	June 07, 2021	June 09, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ATI Physical Therapy, Inc.

Report date June 16, 2021 · Filed June 28, 2021

Jointly reported with ADVENT INTERNATIONAL, L.P., Advent Partners GPE VII-B Cayman Limited Partnership, Advent Partners GPE VII Limited Partnership, Advent Partners GPE VII-A Cayman Limited Partnership, Advent Partners GPE VII-A Limited Partnership, GPE VII ATI Co-Investment Limited Partnership, Advent International GPE VII, LLC, Petrone Carmine

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common Stock, par value $0.0001 per shareSEC Table I · non-derivative	IndirectSee Footnotes	130,300,000	Reported balance Holding disclosure · report date 2021-06-16 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 130,300,000 F1: See Exhibit 99.1 for text of footnote (1) F2: See Exhibit 99.1 for text of footnote (2) F4: See Exhibit 99.1 for text of footnote (4)
Earnout SharesSEC Table II · derivative / convertible security	IndirectSee notes	Not disclosed	Reported balance Holding disclosure · report date 2021-06-16 · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · Balance Not disclosed F3: See Exhibit 99.1 for text of footnote (3) F2: See Exhibit 99.1 for text of footnote (2) F4: See Exhibit 99.1 for text of footnote (4)

Filing footnotes · ownership attribution and instrument terms

F1: See Exhibit 99.1 for text of footnote (1)

F2: See Exhibit 99.1 for text of footnote (2)

F3: See Exhibit 99.1 for text of footnote (3)

F4: See Exhibit 99.1 for text of footnote (4)

Syneos Health, Inc.

Report date June 07, 2021 · Filed June 09, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectSee Notes	273,821	Reported balance After 2021-06-07 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2021-06-07 · Sale · Disposed 6,033,668 · Balance 273,821 F1: See Exhibit 99.1 for text of footnote (1). F4: See Exhibit 99.1 for text of footnote (4). F5: See Exhibit 99.1 for text of footnote (5).
Class A Common StockSEC Table I · non-derivative	IndirectSee Notes	0	Reported balance After 2021-06-07 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2021-06-07 · Sale · Disposed 273,821 · Balance 0 F3: See Exhibit 99.1 for text of footnote (3). F2: See Exhibit 99.1 for text of footnote (2). F4: See Exhibit 99.1 for text of footnote (4). F5: See Exhibit 99.1 for text of footnote (5).

Filing footnotes · ownership attribution and instrument terms

F1: See Exhibit 99.1 for text of footnote (1).

F2: See Exhibit 99.1 for text of footnote (2).

F3: See Exhibit 99.1 for text of footnote (3).

F4: See Exhibit 99.1 for text of footnote (4).

F5: See Exhibit 99.1 for text of footnote (5).

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Cotiviti Holdings, Inc.

Report date August 27, 2018 · Filed August 29, 2018

Section 16 reporting ended · disclosed 2018-08-29. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	0	Reported balance After 2018-08-27 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2018-08-27 · Disposition to issuer · Disposed 41,433,699 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement") among Verscend Technologies, Inc., Rey Merger Sub, Inc. and Cotiviti Holdings, Inc. (the "Issuer") dated as of June 19, 2018. At the effective time of the merger (the "Effective Time") as contemplated in the Merger Agreement, each share of outstanding Issuer common stock immediately prior to the Effective Time was cancelled in exchange for $44.75 per share. F2: The Reporting Person is a Managing Partner at Advent International Corporation ("AIC") and in addition may have limited partnership or other interests in one or more of the Advent Entities (as defined below). AIC manages funds that collectively own 41,433,699 shares (the "Shares"), which are represented as follows: 17,778,618 shares which were held directly by Advent-Cotiviti Acquisition Limited Partnership, 18,817,920 which were held directly by Advent-Cotiviti Acquisition II Limited Partnership, 918,209 shares which were directly owned by Advent International GPE VI-C Limited Partnership, 875,864 shares which were directly owned by Advent International GPE VI-D Limited Partnership, 2,215,460 shares which were directly owned by Advent International GPE VI-E Limited Partnership, 651,453 shares which were directly owned by Advent Partners GPE VI 2008 Limited Partnership, (CONTINUED IN NEXT FOOTNOTE) F3: CONTINUED FROM PREVIOUS FOOTNOTE) 19,762 shares which were directly owned by Advent Partners GPE VI 2009 Limited Partnership 46,608 shares which were directly owned by Advent Partners GPE VI 2010 Limited Partnership, 51,762 shares which were directly owned by Advent Partners GPE VI-A 2010 Limited Partnership and 58,043 shares which were directly owned by Advent Partners GPE VI-A Limited Partnership (collectively and together with certain other affiliates of Advent, the "Advent Entities"). The Reporting Person disclaims Section 16 beneficial ownership of the Shares except to the extent of his pecuniary interest therein, if any, and the reference to these Shares in this report shall not be deemed an admission of beneficial ownership of all of the Shares for purposes of Section 16 or any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement") among Verscend Technologies, Inc., Rey Merger Sub, Inc. and Cotiviti Holdings, Inc. (the "Issuer") dated as of June 19, 2018. At the effective time of the merger (the "Effective Time") as contemplated in the Merger Agreement, each share of outstanding Issuer common stock immediately prior to the Effective Time was cancelled in exchange for $44.75 per share.

F2: The Reporting Person is a Managing Partner at Advent International Corporation ("AIC") and in addition may have limited partnership or other interests in one or more of the Advent Entities (as defined below). AIC manages funds that collectively own 41,433,699 shares (the "Shares"), which are represented as follows: 17,778,618 shares which were held directly by Advent-Cotiviti Acquisition Limited Partnership, 18,817,920 which were held directly by Advent-Cotiviti Acquisition II Limited Partnership, 918,209 shares which were directly owned by Advent International GPE VI-C Limited Partnership, 875,864 shares which were directly owned by Advent International GPE VI-D Limited Partnership, 2,215,460 shares which were directly owned by Advent International GPE VI-E Limited Partnership, 651,453 shares which were directly owned by Advent Partners GPE VI 2008 Limited Partnership, (CONTINUED IN NEXT FOOTNOTE)

F3: CONTINUED FROM PREVIOUS FOOTNOTE) 19,762 shares which were directly owned by Advent Partners GPE VI 2009 Limited Partnership 46,608 shares which were directly owned by Advent Partners GPE VI 2010 Limited Partnership, 51,762 shares which were directly owned by Advent Partners GPE VI-A 2010 Limited Partnership and 58,043 shares which were directly owned by Advent Partners GPE VI-A Limited Partnership (collectively and together with certain other affiliates of Advent, the "Advent Entities"). The Reporting Person disclaims Section 16 beneficial ownership of the Shares except to the extent of his pecuniary interest therein, if any, and the reference to these Shares in this report shall not be deemed an admission of beneficial ownership of all of the Shares for purposes of Section 16 or any other purpose.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 07, 2021 Filed Jun 9, 2021 17:55 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	273,821	$81.20	$22,234,265.20	Disclosure SEC source: 0001140361-21-020415 · form4.xml · nonDerivative · entry 2 Maldonado John L. · CIK 0001544918 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 0 F3 · kind: See Exhibit 99.1 for text of footnote (3). F2 · shares: See Exhibit 99.1 for text of footnote (2). F3 · balance_after: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document
June 07, 2021 Filed Jun 9, 2021 17:55 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	6,033,668	$81.20	$489,933,841.60	Disclosure SEC source: 0001140361-21-020415 · form4.xml · nonDerivative · entry 1 Maldonado John L. · CIK 0001544918 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 273,821 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document
May 14, 2021 Filed May 18, 2021 20:22 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	448,942	$81.04	$36,382,259.68	Disclosure SEC source: 0001140361-21-017948 · form4.xml · nonDerivative · entry 1 Maldonado John L. · CIK 0001544918 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 6,307,489 F1 · kind: See Exhibit 99.1 for text of footnote (1). F2 · shares: See Exhibit 99.1 for text of footnote (2). F3 · balance_after: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document
May 06, 2021 Filed May 10, 2021 21:53 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	216,666	$81.04	$17,558,612.64	Disclosure SEC source: 0001140361-21-016738 · form4.xml · nonDerivative · entry 2 Maldonado John L. · CIK 0001544918 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 6,756,431 F3 · kind: See Exhibit 99.1 for text of footnote (3). F2 · shares: See Exhibit 99.1 for text of footnote (2). F3 · balance_after: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document
May 06, 2021 Filed May 10, 2021 21:53 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	3,791,652	$81.04	$307,275,478.08	Disclosure SEC source: 0001140361-21-016738 · form4.xml · nonDerivative · entry 1 Maldonado John L. · CIK 0001544918 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 6,973,097 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document
March 03, 2021 Filed Mar 5, 2021 19:52 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	322,824	$74.18	$23,945,470.20	Disclosure SEC source: 0001140361-21-007553 · form4.xml · nonDerivative · entry 2 Maldonado John L. · CIK 0001544918 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 10,764,749 F3 · kind: See Exhibit 99.1 for text of footnote (3). F2 · shares: See Exhibit 99.1 for text of footnote (2). F3 · balance_after: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document
March 03, 2021 Filed Mar 5, 2021 19:52 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	4,331,222	$74.18	$321,268,391.85	Disclosure SEC source: 0001140361-21-007553 · form4.xml · nonDerivative · entry 1 Maldonado John L. · CIK 0001544918 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 11,087,573 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document
December 03, 2020 Filed Dec 7, 2020 17:18 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	3,228,241	$61.28	$197,826,608.48	Disclosure SEC source: 0001140361-20-027537 · form4.xml · nonDerivative · entry 1 Maldonado John L. · CIK 0001544918 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 15,418,795 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F2 · balance_after: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). Read SEC document
September 17, 2020 Filed Sep 21, 2020 21:54 UTC	Syneos Health, Inc. SYNH · Entity 109360	SaleClass A Common Stock	3,766,281	$59.26	$223,189,812.06	Disclosure SEC source: 0001140361-20-021061 · form4.xml · nonDerivative · entry 1 Maldonado John L. · CIK 0001544918 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 18,647,036 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F2 · balance_after: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). Read SEC document
August 27, 2018 Filed Aug 29, 2018 16:11 UTC	Cotiviti Holdings, Inc. COTV · Entity 163909	Disposition to issuerCommon Stock	41,433,699	$44.75	$1,854,158,030.25	Disclosure SEC source: 0001209191-18-048790 · doc4.xml · nonDerivative · entry 1 Maldonado John L. · CIK 0001544918 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement") among Verscend Technologies, Inc., Rey Merger Sub, Inc. and Cotiviti Holdings, Inc. (the "Issuer") dated as of June 19, 2018. At the effective time of the merger (the "Effective Time") as contemplated in the Merger Agreement, each share of outstanding Issuer common stock immediately prior to the Effective Time was cancelled in exchange for $44.75 per share. F2 · ownership.nature: The Reporting Person is a Managing Partner at Advent International Corporation ("AIC") and in addition may have limited partnership or other interests in one or more of the Advent Entities (as defined below). AIC manages funds that collectively own 41,433,699 shares (the "Shares"), which are represented as follows: 17,778,618 shares which were held directly by Advent-Cotiviti Acquisition Limited Partnership, 18,817,920 which were held directly by Advent-Cotiviti Acquisition II Limited Partnership, 918,209 shares which were directly owned by Advent International GPE VI-C Limited Partnership, 875,864 shares which were directly owned by Advent International GPE VI-D Limited Partnership, 2,215,460 shares which were directly owned by Advent International GPE VI-E Limited Partnership, 651,453 shares which were directly owned by Advent Partners GPE VI 2008 Limited Partnership, (CONTINUED IN NEXT FOOTNOTE) F3 · ownership.nature: CONTINUED FROM PREVIOUS FOOTNOTE) 19,762 shares which were directly owned by Advent Partners GPE VI 2009 Limited Partnership 46,608 shares which were directly owned by Advent Partners GPE VI 2010 Limited Partnership, 51,762 shares which were directly owned by Advent Partners GPE VI-A 2010 Limited Partnership and 58,043 shares which were directly owned by Advent Partners GPE VI-A Limited Partnership (collectively and together with certain other affiliates of Advent, the "Advent Entities"). The Reporting Person disclaims Section 16 beneficial ownership of the Shares except to the extent of his pecuniary interest therein, if any, and the reference to these Shares in this report shall not be deemed an admission of beneficial ownership of all of the Shares for purposes of Section 16 or any other purpose. Read SEC document
August 10, 2017 Filed Aug 14, 2017 16:08 UTC	Cotiviti Holdings, Inc. COTV · Entity 163909	SaleCommon Stock	9,257,651	$36.87	$341,329,592.37	Disclosure SEC source: 0001209191-17-048748 · doc4.xml · nonDerivative · entry 1 Maldonado John L. · CIK 0001544918 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 41,433,699 F1 · ownership.nature: The Reporting Person is a Managing Partner at Advent International Corporation ("AIC") and in addition may have limited partnership or other interests in one or more of the Advent Entities (as defined below). AIC manages funds that collectively own 41,433,699 shares (the "Shares"), which are represented as follows: 17,778,618 shares held directly by Advent-Cotiviti Acquisition Limited Partnership, 18,817,920 held directly by Advent-Cotiviti Acquisition II Limited Partnership, 918,209 shares directly owned by Advent International GPE VI-C Limited Partnership, 875,864 shares directly owned by Advent International GPE VI-D Limited Partnership, 2,215,460 shares directly owned by Advent International GPE VI-E Limited Partnership, 651,453 shares directly owned by Advent Partners GPE VI 2008 Limited Partnership, (CONTINUED IN NEXT FOOTNOTE) F2 · ownership.nature: CONTINUED FROM PREVIOUS FOOTNOTE) 19,762 shares directly owned by Advent Partners GPE VI 2009 Limited Partnership 46,608 shares directly owned by Advent Partners GPE VI 2010 Limited Partnership, 51,762 shares directly owned by Advent Partners GPE VI-A 2010 Limited Partnership and 58,043 shares directly owned by Advent Partners GPE VI-A Limited Partnership (collectively and together with certain other affiliates of Advent, the "Advent Entities"). The Reporting Person disclaims Section 16 beneficial ownership of the Shares except to the extent of his pecuniary interest therein, if any, and the reference to these Shares in this report shall not be deemed an admission of beneficial ownership of all of the Shares for purposes of Section 16 or any other purpose. Read SEC document
March 13, 2017 Filed Mar 15, 2017 12:09 UTC	Cotiviti Holdings, Inc. COTV · Entity 163909	SaleCommon Stock	8,011,580	$34.38	$275,438,120.40	Disclosure SEC source: 0001209191-17-020712 · doc4.xml · nonDerivative · entry 1 Maldonado John L. · CIK 0001544918 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 50,691,350 F1 · ownership.nature: The Reporting Person is a Managing Partner at Advent International Corporation ("AIC") and in addition may have limited partnership or other interests in one or more of the Advent Entities (as defined below). AIC manages funds that collectively own 50,691,350 shares (the "Shares"), which are represented as follows: 21,750,944 shares held directly by Advent-Cotiviti Acquisition Limited Partnership, 23,022,463 held directly by Advent-Cotiviti Acquisition II Limited Partnership, 1,123,367 shares directly owned by Advent International GPE VI-C Limited Partnership, 1,071,561 shares directly owned by Advent International GPE VI-D Limited Partnership, 2,710,467 shares directly owned by Advent International GPE VI-E Limited Partnership, 797,009 shares directly owned by Advent Partners GPE VI 2008 Limited Partnership, (CONTINUED IN NEXT FOOTNOTE) F2 · ownership.nature: CONTINUED FROM PREVIOUS FOOTNOTE) 24,178 shares directly owned by Advent Partners GPE VI 2009 Limited Partnership 57,022 shares directly owned by Advent Partners GPE VI 2010 Limited Partnership, 63,327 shares directly owned by Advent Partners GPE VI-A 2010 Limited Partnership and 71,012 shares directly owned by Advent Partners GPE VI-A Limited Partnership (collectively and together with certain other affiliates of Advent, the "Advent Entities"). The Reporting Person disclaims Section 16 beneficial ownership of the Shares except to the extent of his pecuniary interest therein, if any, and the reference to these Shares in this report shall not be deemed an admission of beneficial ownership of all of the Shares for purposes of Section 16 or any other purpose. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.